AU2338992A - Carbonate-substituted imidazo(4,5-d) pyridazine compounds for treatment of cardiovascular disorders - Google Patents

Carbonate-substituted imidazo(4,5-d) pyridazine compounds for treatment of cardiovascular disorders

Info

Publication number
AU2338992A
AU2338992A AU23389/92A AU2338992A AU2338992A AU 2338992 A AU2338992 A AU 2338992A AU 23389/92 A AU23389/92 A AU 23389/92A AU 2338992 A AU2338992 A AU 2338992A AU 2338992 A AU2338992 A AU 2338992A
Authority
AU
Australia
Prior art keywords
carbonate
treatment
cardiovascular disorders
substituted imidazo
pyridazine compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU23389/92A
Inventor
Philippe R Bovy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Publication of AU2338992A publication Critical patent/AU2338992A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
AU23389/92A 1991-07-26 1992-07-21 Carbonate-substituted imidazo(4,5-d) pyridazine compounds for treatment of cardiovascular disorders Abandoned AU2338992A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73632991A 1991-07-26 1991-07-26
US736329 1991-07-26

Publications (1)

Publication Number Publication Date
AU2338992A true AU2338992A (en) 1993-03-02

Family

ID=24959460

Family Applications (1)

Application Number Title Priority Date Filing Date
AU23389/92A Abandoned AU2338992A (en) 1991-07-26 1992-07-21 Carbonate-substituted imidazo(4,5-d) pyridazine compounds for treatment of cardiovascular disorders

Country Status (2)

Country Link
AU (1) AU2338992A (en)
WO (1) WO1993003033A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19501831A1 (en) 1995-01-21 1996-07-25 Koehler Dieter Dr Device for producing an aerosol from a powdery substance
BR9810508A (en) * 1997-07-03 2000-09-05 Du Pont Pharm Co Compound, pharmaceutical composition and method of treating a disorder
US6365589B1 (en) 1998-07-02 2002-04-02 Bristol-Myers Squibb Pharma Company Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
US6124463A (en) * 1998-07-02 2000-09-26 Dupont Pharmaceuticals Benzimidazoles as corticotropin release factor antagonists
SE9903028D0 (en) 1999-08-27 1999-08-27 Astra Ab New use
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CA2688161C (en) 2007-06-04 2020-10-20 Kunwar Shailubhai Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2522968T3 (en) 2008-06-04 2014-11-19 Synergy Pharmaceuticals Inc. Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2624828T3 (en) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer and others
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
JP6606491B2 (en) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド Ultra high purity agonist of guanylate cyclase C, method for producing and using the same
AR108906A1 (en) 2016-06-29 2018-10-10 Bristol Myers Squibb Co BIARILMETILE HETEROCICLES

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE64514B1 (en) * 1989-05-23 1995-08-09 Zeneca Ltd Azaindenes
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc Di-substituted imidazo fused 6-membered nitrogen-containing heterocycles and pharmaceutical compositions containing them
EP0415886A3 (en) * 1989-08-30 1991-10-23 Ciba-Geigy Ag Aza compounds
AU653524B2 (en) * 1990-06-08 1994-10-06 Roussel-Uclaf New imidazole derivatives, their preparation process, the new intermediates obtained, their use as medicaments and the pharmaceutical compositions containing them
AU7983691A (en) * 1990-06-15 1992-01-07 G.D. Searle & Co. 1h-substituted-imidazo{4,5-d}pyridazine compounds for treatment of cardiovascular disorders
EP0470543A1 (en) * 1990-08-10 1992-02-12 Dr. Karl Thomae GmbH Heterocyclic imidazoles, remedies containing them and processes for their preparation

Also Published As

Publication number Publication date
WO1993003033A1 (en) 1993-02-18

Similar Documents

Publication Publication Date Title
AU1687592A (en) 5-arylheteroarylalkyl-1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
AU7983691A (en) 1h-substituted-imidazo{4,5-d}pyridazine compounds for treatment of cardiovascular disorders
AU2338992A (en) Carbonate-substituted imidazo(4,5-d) pyridazine compounds for treatment of cardiovascular disorders
AU2620388A (en) Imidazo(1,2-a)(pyridazines or pyrazines) for treatment of diseases related to bone loss
AU7903091A (en) N-substituted-1,2,4-triazolone compounds for treatment of cardiovascular disorders
AU3007492A (en) Treatment of wastewater
EP0516433A3 (en) Process for the preparation of titanyl phthalocyanines
AU2097988A (en) Imidazo (1,2-b) pyridazin-2-yl carbamate derivatives
PL295306A1 (en) Method of obtaining novel derivatives of imidazo /2,1-b/benzothiazolo-3-acetamide
AU1142192A (en) Process for the preparation of 13c-labelled compounds
GB9410441D0 (en) Azabicycloakyl derivatives of imidazo (1,5-a) indol-3-one and process for their preparation
AU8463691A (en) Processes for the preparation of nitrogen-containing compounds
EP0436831A3 (en) Imidazo(1,2-a)pyridinylalkyl compounds for treatment of neurotoxic injury
AU2812692A (en) Processes for the preparation of substituted 1,2,4-triazolo- (1,5-a) (1,3,5)triazines
AU3237984A (en) Imidazo (1,5-a) (1,4) benzodiazepines
AU8464091A (en) Processes for the preparation of hydroxyl-containing compounds
AU2297192A (en) Optically pure s(-) nadolol for treatment of cardiovascular disorders
EP0590259A3 (en) Process for the preparation of halogenated aromatic compounds
AU1175692A (en) Effluent treatment
EP0537589A3 (en) Process for the preparation of dinitro- and diaminophenoxy compounds
EP0548895A3 (en) Process for the preparation of pure diasteroisomers of tetrahydrofolates
AU608865B2 (en) Treatment of cerebral disorders
HU905312D0 (en) Preparation for the treating of psoriasis topicalis
EP0538686A3 (en) Process for the preparation of 2,2,-bis-hydroxymethyl-butanediol-(1,4)
AU2261488A (en) Imidazo(1,2-b)pyridazines